Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders
source: unsplash.com

Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

According to a story from World Pharma Today, Andelyn Biosciences, Inc., which is a gene therapy Contract Development and Manufacturing Organization (CDMO), has recently struck a partnership with Odylia Therapeutics,…

Continue Reading Two Partners Come Together to Manufacture Gene Therapy for RPGRIP1-Related Vision Disorders

New Investigative Therapy Holds Promise for Retinitis Pigmentosa in Mouse Model

Researchers from Nanoscope, thanks to funding by the NIH, have developed a protein that can effectively restore vision in mice. This study was published in Nature Gene Therapy. The Study…

Continue Reading New Investigative Therapy Holds Promise for Retinitis Pigmentosa in Mouse Model

CRISPR Gene Editing Promises to Cure 10,000 diseases. Now in Its First Human Clinical Trial. Will it Eventually Deliver?

  Clustered Regularly Interspaced Short Palindromic Repeats is more commonly known as CRISPR. As reported recently in Science News, the CRISPR/Cas9 “molecular scissors” is slated to make its highly anticipated debut…

Continue Reading CRISPR Gene Editing Promises to Cure 10,000 diseases. Now in Its First Human Clinical Trial. Will it Eventually Deliver?

The World’s First Editing of DNA in Humans Using CRISPR to Treat Leber Congenital Amaurosis

  Allergan plc, a leading global pharmaceutical company, and its partner, Editas Medicine, Inc. have been given the green light for a clinical trial designed to treat patients with severe…

Continue Reading The World’s First Editing of DNA in Humans Using CRISPR to Treat Leber Congenital Amaurosis
Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Free-Photos / Pixabay

Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis

According to a story from pm360online.com, the drug developer Novartis has recently announced that the company's gene therapy Luxturna has gained approval in the EU as a treatment for Leber's…

Continue Reading Single Use Gene Therapy Approved in the EU for Leber’s Congenital Amaurosis
Cryo-Electron Imaging Provides New Info About Virus Vectors in Gene Therapy
kennethr / Pixabay

Cryo-Electron Imaging Provides New Info About Virus Vectors in Gene Therapy

According to a story from EurekAlert!, a collaborative team of researchers from the University of Florida and The Salk Institute are using cryo-electron microscopy in order to more closely examine…

Continue Reading Cryo-Electron Imaging Provides New Info About Virus Vectors in Gene Therapy
ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis
Source: Pixabay

ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis

The FDA, US Food and Drug Administration, unanimously agreed upon the recommendation for a new gene therapy that treats a rare form of blindness, reported ScienceNordic. Spark Therapeutics, a biotech…

Continue Reading ICYMI: FDA In Favor Of Luxturna, A Gene Therapy For Leber Congenital Amaurosis
Company Developing Treatment for Rare Childhood Blindness Gets Special FDA Designation
Source: Pixabay

Company Developing Treatment for Rare Childhood Blindness Gets Special FDA Designation

The FDA has granted a special designation for a drug company developing a gene therapy for the treatment of leber congenital amaurosis (LCA). MeiraGTx received rare pediatric disease designation for its…

Continue Reading Company Developing Treatment for Rare Childhood Blindness Gets Special FDA Designation
“Fishing” for a Cure for Leber Congenital Amaurosis
https://pixabay.com/en/fisherman-boat-inle-lake-myanmar-239487/

“Fishing” for a Cure for Leber Congenital Amaurosis

By examining a zebrafish, scientists have found the gene that affects the maintenance of cone photoreceptors and visual functions in the eye. It might be the knowledge that’s been needed…

Continue Reading “Fishing” for a Cure for Leber Congenital Amaurosis
A New Treatment May Be Coming for Leber Congenital Amaurosis
https://pixabay.com/en/eye-iris-macro-natural-girl-2340806/

A New Treatment May Be Coming for Leber Congenital Amaurosis

Case Western Reserve University researchers have recently developed gene-carrying nanoparticles that are able to bring healthy genes to those negatively affected by Leber congenital amaurosis (LCA), a disease that causes…

Continue Reading A New Treatment May Be Coming for Leber Congenital Amaurosis